Portola Pharmaceuticals   Print Page    Close Window

Keyword Search
2019 | 2018 | 2017 | 2016
February 07, 2019Portola Pharmaceuticals Announces Full Results from the ANNEXA-4 Study of the Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Life-Threatening BleedingPrinter Friendly Version
February 01, 2019Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on Friday, March 1, 2019Printer Friendly Version
January 30, 2019Portola Pharmaceuticals to Present Full Results from the ANNEXA-4 Study of Andexxa During a Late-Breaking Oral Presentation at the International Stroke Conference 2019Printer Friendly Version
January 28, 2019Portola Pharmaceuticals Appoints Sheldon Koenig as Chief Commercial OfficerPrinter Friendly Version